{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:36:31Z","timestamp":1777941391002,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.msard.2024.106213","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T15:28:15Z","timestamp":1733758095000},"page":"106213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["One-year risk of multiple sclerosis after a first episode of optic neuritis according to modern diagnosis criteria"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3355-7715","authenticated-orcid":false,"given":"Pierre","family":"Lebranchu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Driss","family":"Mazhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Wiertlewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guyl\u00e8ne","family":"Le Meur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine","family":"Couturier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Baptiste","family":"Ducloyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2024.106213_bib0001","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/archopht.1995.01100020014004","article-title":"The optic neuritis treatment trial: three-year follow-up results","volume":"113","author":"Beck","year":"1995","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.msard.2024.106213_bib0002","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJM199312093292403","article-title":"The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. the optic neuritis study group","volume":"329","author":"Beck","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2024.106213_bib0003","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archopht.121.7.944","article-title":"High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial","volume":"121","author":"Beck","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.msard.2024.106213_bib0004","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/jamaneurol.2020.3502","article-title":"Trends in optic neuritis incidence and prevalence in the UK and association with systemic and neurologic disease","volume":"77","author":"Braithwaite","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2024.106213_bib0005","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neurad.2020.01.083","article-title":"New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions","volume":"47","author":"Brisset","year":"2020","journal-title":"J. Neuroradiol."},{"key":"10.1016\/j.msard.2024.106213_bib0006","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","article-title":"Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study","volume":"357","author":"Comi","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2024.106213_bib0007","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/ene.13315","article-title":"Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients","volume":"24","author":"Deschamps","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2024.106213_bib0008","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/bjophthalmol-2019-314845","article-title":"MOG-Ab prevalence in optic neuritis and clinical predictive factors for diagnosis","volume":"104","author":"Ducloyer","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.msard.2024.106213_bib0009","article-title":"Optic neuritis classification in 2021","author":"Ducloyer","year":"2021","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.msard.2024.106213_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.540156","article-title":"AQP4-IgG and MOG-IgG related optic neuritis-prevalence, optical coherence tomography findings, and visual outcomes: a systematic review and meta-analysis","volume":"11","author":"Filippatou","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2024.106213_bib0011","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/brain\/awm329","article-title":"Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis","volume":"131","author":"Fisniku","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.msard.2024.106213_bib0012","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.msard.2011.08.002","article-title":"The diagnostic criteria for multiple sclerosis: from charcot to McDonald","volume":"1","author":"Gafson","year":"2012","journal-title":"Mult. Scler Relat. Disord."},{"key":"10.1016\/j.msard.2024.106213_bib0013","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00415-018-09169-w","article-title":"Long-term follow-up of multiple sclerosis studies and outcomes from early treatment of clinically isolated syndrome in the BENEFIT 11 study","volume":"267","author":"Hartung","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2024.106213_bib0014","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajo.2020.07.014","article-title":"Population-based incidence of optic neuritis in the era of aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies","volume":"220","author":"Hassan","year":"2020","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.msard.2024.106213_bib0015","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1474-4422(09)70237-6","article-title":"Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial","volume":"8","author":"Kappos","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2024.106213_bib0016","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/09286586.2019.1621352","article-title":"Adherence to clinical trial supported evaluation of optic neuritis","volume":"26","author":"Meer","year":"2019","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.msard.2024.106213_bib0017","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(11)70274-5","article-title":"Clinically isolated syndromes","volume":"11","author":"Miller","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2024.106213_bib0018","first-page":"727","article-title":"Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up","volume":"65","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2024.106213_bib0019","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/WNL.49.5.1404","article-title":"The 5-year risk of MS after optic neuritis. experience of the optic neuritis treatment trial","volume":"49","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.106213_bib0020","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1177\/1352458517734070","article-title":"A population-based prospective study of optic neuritis","volume":"23","author":"Soelberg","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.106213_bib0021","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2024.106213_bib0022","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/01.wnl.0000237354.10144.ec","article-title":"Baseline MRI predicts future attacks and disability in clinically isolated syndromes","volume":"67","author":"Tintor\u00e9","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.106213_bib0023","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/01.wnl.0000280576.73609.c6","article-title":"Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?","volume":"70","author":"Tintor\u00e9","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.106213_bib0024","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824007892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824007892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T20:59:23Z","timestamp":1738184363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824007892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":24,"alternative-id":["S2211034824007892"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.106213","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One-year risk of multiple sclerosis after a first episode of optic neuritis according to modern diagnosis criteria","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.106213","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106213"}}